KG LEGAL \ INFO
BLOG

Development of the Polish medical and pharmaceutical industry

The Polish medical and pharmaceutical industry has a long tradition. In recent years, its structure and dynamics have changed significantly. The domestic pharmaceutical industry is one of the strategic industries of the Polish economy. It plays a key role in the whole healthcare system, providing Polish patients with examined, effective, high-quality and affordable medicines. Most Polish pharmaceutical companies have been privatized and numerous companies have been taken over by large foreign pharmaceutical corporations. In addition, new successful companies are emerging, which thanks to their innovation and implementation of new technologies, are entering foreign markets and becoming competitors of foreign companies. They also contribute to a significant increase in the competitiveness of the Polish economy.

Development in figures

More

Standard contractual clauses process data of European Union citizens outside the Union

This article focuses on the legal aspects of transferring personal data of European Union citizens outside the European Union. It can be of interest, particularly having in mind cases handled by our law firm in the field of transferring personal data of patients of medical online platforms in telemedicine, in the machine collection of sensitive data using webscraping methods, and in the field of collecting and transferring data and creating databases of financial services users in broadly understood fintech sector. The problem is also significant from the point of view of clients of our law firm providing online gaming, online gambling, e-sports betting and e-betting services.

New standard contractual clauses

More

KIELTYKA GLADKOWSKI WILL TAKE PART IN COHNREZNICK WEBINAR ON DEAL ACTIVITY IN HEALTHCARE SERVICES

On October 14, 2021 KIELTYKA GLADKOWSKI will take part in a webinar organised by CohnReznick, focused on plans for healthcare services investment.

As deal activity in healthcare services reached an all-time high in 2020 and last year, the suddenness of the COVID-19 pandemic prompted investors and healthcare providers to look to the M&A market in record numbers, the organisers of the webinar will discuss the environment, trends and deals (closed and planned to expand existing and explore new platforms).

As providers continue to adjust their business models and the ways they provide care to their patients, Private Equity and M&A statistics offer tea leaves into how they plan to do that. The panelists will therefore provide insights on investment trends, healthcare company value drivers and opportunities for the sector.

More

Trends in healthcare sector investments

KIEŁTYKA GŁADKOWSKI KG LEGAL constantly supervises and prepares its lawyers for the specialization in which they provide services for foreign clients. In order to systematize the conceptual grid of very specialized fields of pharma, biology, medicine and life sciences as well as new tech in healthcare KIEŁTYKA GŁADKOWSKI conducts internal consultations to improve the experience of our lawyers specializing in legal assistance for foreign clients from life science and tech sector. As a result of such internal research, KIEŁTYKA GŁADKOWSKI creates and publishes texts on topics related to modern legal problems, but also to explain the basic concepts of specialized life sciences and pharmaceutical fields. In this way, KIEŁTYKA GŁADKOWSKI aims to demonstrate to potential clients within specialized industries that our lawyers are also familiar with specialist terms necessary for a proper understanding of our foreign client’s business and legal needs.

This is one of those texts. We invite you to read it.

More

Cosmetic products and responsibility for a dangerous product on the basis of Polish civil law

Johnson & Johnson case

Thousands of lawsuits have been filed against Johnson & Johnson, a company known for its baby products, in recent years – but the most well-known one involves 22 women who alleged that their ovarian cancers have been caused by the baby powder they had been using. After the appeal, by the end of which the amount of money the company had to pay those women was reduced from 4.7 billion to 2.1 billion, Johnson & Johnson took legal steps to present the case before the Supreme Court. The Supreme Court has decided not to consider their case, however, which resulted in leaving in place the last verdict of the Missouri appeals-court.

The link between the illness and the product was supposed to be based on the fact that Johnson & Johnson baby powders contained talc. Talc is oftentimes found in close proximity to asbestos, which is carcinogenic, and in the past the talc has been contaminated with asbestos. It is also worth mentioning, that talk on itself is dangerous while inhaled in large doses but the studies aren’t clear on whether or not it’s carcinogenic on itself.

Although Johnson & Johnson denies that their products are dangerous to health, they will no longer be selling the baby powder containing talc in the US and Canada, focusing instead on the corn-starch-based alternative.

Polish Regulations

More

UP